» Articles » PMID: 26218241

Microorganisms Linked to Inflammatory Bowel Disease-associated Dysbiosis Differentially Impact Host Physiology in Gnotobiotic Mice

Abstract

Studying host-microbiota interactions are fundamental to understanding the mechanisms involved in intestinal homeostasis and inflammation. In this work, we analyzed these interactions in mice that were mono-associated with six microorganisms that are representative of inflammatory bowel disease (IBD)-associated dysbiosis: the bacteria Bacteroides thetaiotaomicron, adhesive-invasive Escherichia coli (AIEC), Ruminococcus gnavus and Roseburia intestinalis; a yeast used as a probiotic drug, Saccharomyces boulardii CNCM I-745; and another yeast, Candida albicans. Extensive ex vivo analyses including colon transcriptomics, histology, immune response, bile acid metabolism and short-chain fatty acid production were studied. We showed that B. thetaiotaomicron had the highest impact on the immune system because it was almost able to recapitulate the effects of the entire conventional microbiota and notably induced Treg pathways. Furthermore, these analyses uncovered the effects of E. coli AIEC LF82 on indoleamine 2,3-dioxygenase expression and of S. boulardii CNCM I-745 on angiogenesis. These results were confirmed in vitro in human cell lines. Finally, our results suggested that R. gnavus has major effects on metabolism, and notably on tryptophan metabolism. This work therefore reveals that microorganisms with a potential role in intestinal homeostasis and inflammation have specific impacts on the host, and it suggests several tracks to follow to understand intestinal homeostasis and IBD pathogenesis better, providing new insights to identify novel therapeutic targets.

Citing Articles

Alleviates Colitis by Regulating FXR-NLRP3 Mediated Macrophage Pyroptosis.

Yang L, Li W, Zhao Q, Mo Q, Liu T, Cao H J Inflamm Res. 2025; 18:3161-3176.

PMID: 40065908 PMC: 11891491. DOI: 10.2147/JIR.S504957.


A systematic review on gut microbiota in type 2 diabetes mellitus.

Chong S, Lin M, Chong D, Jensen S, Lau N Front Endocrinol (Lausanne). 2025; 15:1486793.

PMID: 39897957 PMC: 11782031. DOI: 10.3389/fendo.2024.1486793.


Managing Type 2 Diabetes Mellitus via the Regulation of Gut Microbiota: A Chinese Medicine Perspective.

Ng C, Zhong L, Ng H, Goh K, Zhao Y Nutrients. 2024; 16(22).

PMID: 39599721 PMC: 11597546. DOI: 10.3390/nu16223935.


Gut Microbiota in the Progression of Type 2 Diabetes and the Potential Role of Exercise: A Critical Review.

Deli C, Fatouros I, Poulios A, Liakou C, Draganidis D, Papanikolaou K Life (Basel). 2024; 14(8).

PMID: 39202758 PMC: 11355287. DOI: 10.3390/life14081016.


A randomized, double-blind, placebo-controlled clinical study to evaluate the efficacy and safety of BC99 in the treatment of chronic constipation in adults.

Wu Y, Bai Z, Jin Y, Zhu H, Dong Y, Gu S Front Nutr. 2024; 11:1395083.

PMID: 39119466 PMC: 11306189. DOI: 10.3389/fnut.2024.1395083.


References
1.
Furusawa Y, Obata Y, Fukuda S, Endo T, Nakato G, Takahashi D . Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells. Nature. 2013; 504(7480):446-50. DOI: 10.1038/nature12721. View

2.
Standaert-Vitse A, Sendid B, Joossens M, Francois N, Vandewalle-El Khoury P, Branche J . Candida albicans colonization and ASCA in familial Crohn's disease. Am J Gastroenterol. 2009; 104(7):1745-53. DOI: 10.1038/ajg.2009.225. View

3.
Willing B, Dicksved J, Halfvarson J, Andersson A, Lucio M, Zheng Z . A pyrosequencing study in twins shows that gastrointestinal microbial profiles vary with inflammatory bowel disease phenotypes. Gastroenterology. 2010; 139(6):1844-1854.e1. DOI: 10.1053/j.gastro.2010.08.049. View

4.
Danese S, Sans M, Spencer D, Beck I, Donate F, Plunkett M . Angiogenesis blockade as a new therapeutic approach to experimental colitis. Gut. 2006; 56(6):855-62. PMC: 1954843. DOI: 10.1136/gut.2006.114314. View

5.
Burt S, Meldrum S, Woods D, Jones D . Colonial variation, capsule formation, and bacteriophage resistance in Bacteroides thetaiotaomicron. Appl Environ Microbiol. 1978; 35(2):439-43. PMC: 242850. DOI: 10.1128/aem.35.2.439-443.1978. View